Cash Flow Statement

Altimmune (ALT) Return on Sales Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00
7 Evaxion A 64.16 Bn 64.14 Bn - 4.00
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.00
10 Altimmune 379.61 Mn 379.61 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 6,863.00
Sep 30, 2025 766.00
Jun 30, 2025 499.00
Mar 31, 2025 964.00
Dec 31, 2024 -4,396.00
Sep 30, 2024 -4,512.00
Jun 30, 2024 -2,232.00
Mar 31, 2024 -3,922.00
Dec 31, 2023 -2,205.00
Sep 30, 2023 11,701.00
Jun 30, 2023 -179.00
Mar 31, 2023 -346.00
Dec 31, 2022 1,967.00
Sep 30, 2022 -11,546.00
Jun 30, 2022 -2,335.00
Mar 31, 2022 -593.00
Dec 31, 2021 3.00
Sep 30, 2021 -206.00
Jun 30, 2021 -178.00
Mar 31, 2021 -16.00
Dec 31, 2020 3.00
Sep 30, 2020 11.00
Jun 30, 2020 -1.00
Mar 31, 2020 -1.00
Dec 31, 2019 5.00
Sep 30, 2019 -16.00
Jun 30, 2019 2.00
Mar 31, 2019 0.00
Dec 31, 2018 -7.00
Sep 30, 2018 6.00
Jun 30, 2018 -3.00
Mar 31, 2018 11.00
Dec 31, 2017 -2.00
Sep 30, 2017 968.00
Jun 30, 2017 2.00
Mar 31, 2017 -11.00
Dec 31, 2016 -2.00
Sep 30, 2016 -973.00
Jun 30, 2016 -1.00
Mar 31, 2016 -1.00
Dec 31, 2015 0.00
Sep 30, 2015 4.00
Jun 30, 2015 -2.00
Mar 31, 2015 1.00
Dec 31, 2014 0.00
Sep 30, 2014 -4.00
Jun 30, 2014 0.00
Mar 31, 2014 0.00
Dec 31, 2013 -1.00
Sep 30, 2013 -1.00
Jun 30, 2013 0.00
Mar 31, 2013 0.00
Dec 31, 2012 0.00
Sep 30, 2012 0.00
Jun 30, 2012 0.00
Mar 31, 2012 0.00
Dec 31, 2011 2.00
Sep 30, 2011 1.00
Jun 30, 2011 1.00